Stocks
Amylyx Pharmaceuticals (AMLX) Net margin US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -6 505% | -892.4% | 12.9% | -345.4% | ||||
| Changes by years, y/y, % | -5 466pp | +6 505pp | +905pp | -358pp | -19.8% | ||||
Amylyx Pharmaceuticals. Net margin, %
Amylyx Pharmaceuticals. Net margin, changes, pp
Amylyx Pharmaceuticals (AMLX) Net margin US GAAP (quarter values) |
||||||||
| FY2023Q4 | FY2024Q1 | FY2024Q2 | FY2024Q3 | FY2024Q4 | LTM ? | |||
| Net margin, % | ? | 4.36% | -134.0% | -7 107% | -17 477% | -5 646% | ||
| Changes by years, y/y, % | +199pp | -136pp | -7 129pp | -17 497pp | -5 650pp | |||
| Changes by quarters, q/q, % | -16pp | -138pp | -6 973pp | -10 370pp | +11 831pp | |||
